Just when you thought things couldn’t get any worse for Rite Aid (NYSE: RAD), they did.
The pharmacy chain’s stock has taken a beating throughout 2017 with increasing uncertainty over a now-scrapped acquisition by Walgreens Boots Alliance (NASDAQ: WBA). The drubbing got even worse on Thursday, with Rite Aid announcing its fiscal 2018 second-quarter results. Rite Aid stock traded more than 10% below its previous close soon after the market opened. Here are five key things you need to know from the company’s quarterly update.